|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.20 EUR | -1.54% |
|
-2.04% | -31.43% |
| 1 day | -1.54% | ||
| 1 week | -2.04% | ||
| Current month | -3.52% | ||
| 1 month | -8.57% | ||
| 3 months | -4.95% | ||
| 6 months | -28.89% | ||
| Current year | -31.43% |
| 1 week | 19.1 |  | 19.6 |
| 1 month | 19 | | 21.8 |
| Current year | 19 | | 28 |
| 1 year | 15 | | 30.8 |
| 3 years | 9.16 | | 32.6 |
| 5 years | 5 | | 32.6 |
| 10 years | 5 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | 01/01/2015 | |
Liina Kervemann
DFI | Director of Finance/CFO | - | - |
Erik Berlin
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karita Sall
BRD | Director/Board Member | 52 | - |
Yoann John Ricau
BRD | Director/Board Member | 51 | - |
Martin Wilson
BRD | Director/Board Member | 49 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | -2.04% | -35.14% | +72.97% | 37.4M | |
| +0.15% | +1.04% | +16.34% | +74.17% | 49.38B | |
| +0.53% | +3.50% | +61.24% | +112.76% | 36.35B | |
| +2.50% | +0.21% | -5.74% | +23.32% | 11.87B | |
| -0.81% | -4.33% | +12.58% | +69.24% | 11.53B | |
| +0.38% | -2.06% | +34.70% | +131.86% | 8.99B | |
| -0.92% | -0.35% | +48.24% | -9.27% | 7B | |
| -0.51% | -2.10% | +12.20% | +32.13% | 6.76B | |
| -0.52% | -2.45% | +1.83% | +165.65% | 6.46B | |
| -1.32% | -11.87% | -32.46% | -0.24% | 5.49B | |
| Average | -0.21% | -0.88% | +11.38% | +67.26% | 14.39B | |
| Weighted average by Cap. | +0.21% | +0.58% | +25.54% | +78.17% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | €19.20 | -1.54% | 7 |
| 27/07/26 | €19.50 | 0.00% | 1 |
| 24/07/26 | €19.50 | 0.00% | 30 |
| 23/07/26 | €19.50 | +2.09% | 50 |
| 22/07/26 | €19.10 | 0.00% | 28 |
- Stock Market
- Stocks
- MOLNRIPO Stock
Select your edition
All financial news and data tailored to specific country editions
